ArticleAnnals of internal medicine2015

The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.

Benjamin P Linas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.